Endeavor

Ramping Up the Immune System to Fight Breast Cancer

Clinical trial led by Moffitt evaluates combination immunotherapy for HER2 positive metastatic disease

Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence

Phase 3 trial results could be practice changing for both men and women

Predicting Response to Herpes Virus in Triple-Negative Breast Cancer Patients

New study identifies genetic biomarkers that correlate with higher response rates

Moffitt Scientists Share Innovative Clinical Research at ASCO

The American Society of Clinical Oncology Annual Meeting attracts more than 40,000

New Study Shows Promise for Difficult to Treat Brain Metastases

First in human trial is recruiting patients with leptomeningeal disease from triple- negative or HER2 positive breast cancers

Quitting Smoking? 3 Tips to Beat Your Urges

Moffitt develops programs in English and Spanish to help smokers kick butts

Photo of the Week: Breakthroughs on Display

Moffitt Scientific Symposium attracts a record-breaking 400 attendees

Social Connectedness May Help Ease Depression in Young Cancer Survivors, Study Finds 

Higher levels of social isolation linked to more symptoms of depression and anxiety

The Truth About Clinical Studies: The Most Advanced Cancer Care at Moffitt Cancer Center

Learn more about some common misconceptions that prevent patients from joining clinical trials.